Malvern Institute

Stay Connected With Malvern. Get Email Updates | Follow Us:

FDA encourages new medications for opioid addiction

March 1, 2018 – Removing barriers so individuals struggling with the disease of addiction can access treatment should be a goal for policymakers. Identifying effective and evidence-based methods for treatment – like Malvern Institute utilizes – will assist individuals to begin the recovery process.

The U.S. Food and Drug Administration is expected to bolster medication-assisted treatment options through new guidelines, according to WHYY. These medications could ease withdrawal symptoms and cravings for individuals struggling with addiction:

The new FDA guidelines are part of its strategy for promoting drugs that can ease withdrawal symptoms and cravings for people addicted to opioids.

The guidelines would make it easier to get new medications approved that are shown to help in some way with a patient’s recovery, even if the person doesn’t stop using drugs completely.

“This is moving us in the right direction, but there are a slew of effective drugs that are already out there,” said Dr. Geoffrey Neimark, the chief medical officer for Community Behavioral Health, which runs Philadelphia’s network of addiction treatment providers for people on Medicaid.

Malvern Institute: We Give Hope

If you or a loved one are living with addiction, we can help. Learn about Malvern Intervention Services or the Malvern Model Of Care by calling 610.MALVERN (610.625.8376).

Read the full story from WHYY.


Recent News

Podcast tackles science behind addiction treatment, opioid epidemic

March 30, 2018 – Raising awareness of the facts about the disease of addiction and breaking the stigma associated with addiction are necessary steps toward truly helping families affected by the disease of addiction. This month, Gimlet Media’s “Science Vs.” podcast released two episodes dedi...

Read More

See All News

© 2017 Malvern Institute - All Rights Reserved | View Privacy Policy